Horizant Tablet, Extended Release
Product Images NDC 53451-0103

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Horizant (NDC 53451-0103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Horizant 01)

Chemical structure diagram showing the molecular structure of gabapentin enacarbil, the active ingredient in Horizant. The structure includes carbon, oxygen, nitrogen, and hydrogen atoms arranged in characteristic functional groups and rings representing this compound used in extended-release oral tablets.*

FDA Label Image

Figure 1 (Horizant 02)

A line graph showing mean IRLS total scores over 12 weeks for three treatment groups: placebo, Horizant 600 mg, and Horizant 1200 mg. The x-axis represents study weeks from baseline to week 12, and the y-axis represents mean IRLS total score with error bars for standard deviation. The graph includes sample sizes for each group at different weeks below the x-axis.*

FDA Label Image

Figure 2 (Horizant 03)

A line graph showing the percent of patients improved versus percent improvement in pain from baseline in a clinical study. The graph compares placebo and three doses of Horizant (1,200 mg, 2,400 mg, and 3,600 mg). The x-axis represents percent improvement in pain from baseline, and the y-axis represents the percent of patients improved. The graph indicates different responses across the doses and placebo groups.*

FDA Label Image

Principal Display Panel (300 mg Bottle Label)

Label for Horizant 300 mg extended-release tablets containing gabapentin enacarbil. The label includes dosage form, strength, NDC 53451-0103-1, manufacturer Arbor Pharmaceuticals LLC, storage instructions, and a barcode. It states tablets should be swallowed whole and not interchanged with other gabapentin products.*

FDA Label Image

Principal Display Panel (600 mg Bottle Label)

Label for Horizant 600 mg extended-release tablets, containing gabapentin enacarbil. The label shows a 30 tablet count and the NDC 53451-0101-1. It includes instructions stating tablets should be swallowed whole and not altered. The labeler is Arbor Pharmaceuticals, LLC, with manufacturing in Switzerland. Additional product and storage information is provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.